Alessandro Maselli’s Post

Exciting times for Catalent! We completed our transaction with Novo Holdings and we have become a private company again. We enter our next chapter as a leading global, independent, full-service CDMO, well-positioned to utilize our remaining network of more than 40 global sites to bring our customers’ products through development, clinical trials, commercial product launch and beyond, with unparalleled service every step of the way. As President and CEO, I remain as committed as ever to leading Catalent, driven by our Patient First culture and our mission to develop, manufacture and supply products that help people live better, healthier lives. I would like to thank all our employees for their commitment to making Catalent the incredible company it is today. I am excited for all that we will accomplish together for customers and patients going forward. To read more, please visit:  https://lnkd.in/dYENMpzF